Tc 99m exametazime - Jubilant DraxImage

Drug Profile

Tc 99m exametazime - Jubilant DraxImage

Alternative Names: Drax Exametazime; Technetium 99m exametazime - Jubilant DraxImage; Technetium Tc 99m exametazime - Jubilant DraxImage

Latest Information Update: 07 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Jubilant DraxImage
  • Class Oximes; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Intra-abdominal infections; Irritable bowel syndrome

Most Recent Events

  • 07 Sep 2017 Chemical structure information added
  • 17 Aug 2017 Registered for Intra-abdominal infections (Diagnosis) in USA (IV) (US FDA Approval letter, August 2017)
  • 17 Aug 2017 Registered for Irritable bowel syndrome (Diagnosis) in USA (IV) (US FDA Approval letter, August 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top